• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺腺泡细胞对125I-博尔顿-亨特-P物质的结合与内化

Binding and internalization of 125I-Bolton-Hunter-substance-P by pancreatic acinar cells.

作者信息

Sjödin L

出版信息

Biochem Biophys Res Commun. 1984 Oct 30;124(2):578-84. doi: 10.1016/0006-291x(84)91593-6.

DOI:10.1016/0006-291x(84)91593-6
PMID:6208908
Abstract

Binding of 125I-labelled Bolton-Hunter substance P (125I-BH-SP) to dispersed pancreatic acinar cells from guinea pigs was studied. Association of 125I-BH-SP to acinar cells was rapid, specific, and temperature-dependent. Dissociation of bound 125I-BH-SP was slow and 60 min after dilution only 12% of cell-associated radioactivity had dissociated from cells. Various c-terminal fragments of SP as well as structurally related substances inhibited binding. Bound 125I-BH-SP partly resisted acid washes of cells. After lysis of cells, cell-associated radioactivity was chromatographed on a Sephadex G-25 column. Part of radioactivity was eluted as apparently intact 125I-BH-SP. It is suggested that this material has been internalized into acinar cells.

摘要

研究了¹²⁵I标记的博尔顿-亨特物质P(¹²⁵I-BH-SP)与豚鼠分散胰腺腺泡细胞的结合情况。¹²⁵I-BH-SP与腺泡细胞的结合迅速、具有特异性且依赖温度。结合的¹²⁵I-BH-SP的解离缓慢,稀释60分钟后,仅12%与细胞相关的放射性从细胞中解离。SP的各种C末端片段以及结构相关物质抑制结合。结合的¹²⁵I-BH-SP部分抵抗细胞的酸洗。细胞裂解后,将与细胞相关的放射性在葡聚糖凝胶G-25柱上进行层析。部分放射性以明显完整的¹²⁵I-BH-SP形式洗脱。提示该物质已被内化到腺泡细胞中。

相似文献

1
Binding and internalization of 125I-Bolton-Hunter-substance-P by pancreatic acinar cells.胰腺腺泡细胞对125I-博尔顿-亨特-P物质的结合与内化
Biochem Biophys Res Commun. 1984 Oct 30;124(2):578-84. doi: 10.1016/0006-291x(84)91593-6.
2
A selective and potent antagonist of substance P receptors on pancreatic acinar cells.一种对胰腺腺泡细胞上P物质受体具有选择性和强效的拮抗剂。
Biochem Int. 1992 Jun;27(1):145-53.
3
Cholecystokinin-induced inhibition of endocytosis of receptor-bound substance P in pancreatic acinar cells.胆囊收缩素诱导的胰腺腺泡细胞中受体结合的P物质内吞作用的抑制
J Recept Res. 1992;12(3):323-50. doi: 10.3109/10799899209074799.
4
Functional substance P receptors on a rat pancreatic acinar cell line.大鼠胰腺腺泡细胞系上的功能性P物质受体
J Neurosci. 1985 Dec;5(12):3370-8. doi: 10.1523/JNEUROSCI.05-12-03370.1985.
5
Rapid down-regulation of substance P binding to guinea-pig pancreatic acinar cells during homologous desensitization.在同源脱敏过程中,P物质与豚鼠胰腺腺泡细胞的结合迅速下调。
J Physiol. 1994 Apr 1;476(1):69-77.
6
Specific [125I]Bolton-Hunter substance P binding sites in human and rat skin.人及大鼠皮肤中特异性的[125I]博尔顿-亨特P物质结合位点。
Neurosci Lett. 1989 May 8;99(3):287-92. doi: 10.1016/0304-3940(89)90461-8.
7
Gastric chief cells possess NK1 receptors which mediate pepsinogen secretion and are regulated by agents that increase cAMP and phospholipase C.胃主细胞拥有NK1受体,该受体介导胃蛋白酶原的分泌,并受增加环磷酸腺苷(cAMP)和磷脂酶C的药物调节。
Biochim Biophys Acta. 1996 Jun 13;1312(2):105-16. doi: 10.1016/0167-4889(96)00026-2.
8
Quantitative autoradiographic analysis of the distribution of binding sites for [125I]Bolton Hunter derivatives of eledoisin and substance P in the rat brain.大鼠脑中[125I]伊氏缩胆囊素和P物质的博尔顿-亨特衍生物结合位点分布的定量放射自显影分析。
Neuroscience. 1986 Aug;18(4):857-75. doi: 10.1016/0306-4522(86)90105-3.
9
Comparison of binding assay and biological activity on a NK-1 system with new selective agonists.
Neuropeptides. 1989 Nov-Dec;14(4):275-83. doi: 10.1016/0143-4179(89)90057-7.
10
Demonstration of two distinct tachykinin receptors in rat brain cortex.大鼠大脑皮层中两种不同速激肽受体的证明。
J Biol Chem. 1985 Feb 10;260(3):1501-7.

引用本文的文献

1
The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy.NK1受体配体的意义及其在靶向放射性核素肿瘤治疗中的应用。
Pharmaceutics. 2019 Sep 1;11(9):443. doi: 10.3390/pharmaceutics11090443.
2
Agonist-induced substance P receptor down-regulation in rat central nervous system.激动剂诱导的大鼠中枢神经系统中P物质受体下调
Pharm Res. 1988 Dec;5(12):795-9. doi: 10.1023/a:1015996920198.